Stock PHM PATIENT HOME MONITORING CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Patient Home Monitoring Corp. Toronto S.E.

Equities

PHM

CA70324G1063

End-of-day quote Toronto S.E.
Other stock markets
- CAD - Intraday chart for Patient Home Monitoring Corp.
05-20 Benchmark Trims Price Target on Quipt Home Medical to $9 From $10, Maintains Buy Rating MT
05-17 Canaccord Genuity Adjusts Price Target on Quipt Home Medical to $8 From $9, Maintains Buy Rating MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Quipt Home Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
CI
Quipt Home Medical Corp. Brief: Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue
MT
Quipt Home Medical Corp. Brief: Revenue for Q2 2024 was US$64.0 million compared to $58.1 million for Q2 2023, representing a 10% increase
MT
Quipt Home Medical Corp. announces an Equity Buyback for 3,626,845 shares, representing 8.52% of its issued share capital.
CI
Quipt Home Medical Announces 10% Stock Buyback
MT
Quipt Home Medical Corp. authorizes a Buyback Plan.
CI
Quipt Home Medical Corp. Brief: Revenue for Q1 2024 was US$65.4 million compared to $40.8 million for Q1 2023; Net income (loss) for Q1 2024 was $(0.6) million, or ($0.01) per diluted share
MT
Quipt Home Medical Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
Quipt Home Medical Corp. Brief: Shelf Prospectus and Registration Statement, when made final and effective, will enable Co to offer Up to C$300,000,000 of common shares, preferred shares, debt securities, warrants
MT
Quipt Home Medical Corp. Brief: Announced Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus
MT
Quipt Home Medical Corp. Up 3% In US After Hours Despite Q4 Net Loss; But Revs and Recurring Revs "Very Strong"
MT
Quipt Home Medical Corp. Brief: Adds Company "Maintains a conservative balance sheet" with net debt to Adjusted EBITDA leverage of 1.4x
MT
Quipt Home Medical Corp. Brief: Says Recurring Revenue for Q4 2023 was "Very Strong" and Exceeded 83% of total revenue, driven by growth in the Company's resupply platform
MT
Quipt Home Medical Corp. Brief: Revenue for Q4 2023 was US$62.5 million compared to $40.1 million for Q4 2022, representing a 56% increase
MT
Quipt Home Medical Corp. Brief: Net Loss for Q4 2023 was US($1.3) million, or ($0.03) per diluted share, as compared to $1.8 million, or $0.05 per diluted share for Q4 2022
MT
Quipt Home Medical Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2023
CI
Quipt Home Medical Corp. Announces Multi-State Acquisition Adding Near US$9 Million in Annualized Revenues
MT
Quipt Home Medical Corp. Brief: Announcing Multi-State Acquisition Adding Near US$9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration
MT
Quipt Home Medical Reports 64% YoY Increase in Revenue, to US$60.3 Million
MT
Refile-- Quipt Home Medical Brief: Revenues for fiscal Q3 2023 were US$60.3 million
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QIPT Stock
  4. PHM Stock
  5. News Patient Home Monitoring Corp.
  6. Highlights